Search ISOPP's Oncology Pharmacy Resources for materials related to oncology pharmacy research and practice including past ISOPP Symposia resources and journal enewsletters. You can search using a key word or on a topic area.
ISOPP members have full access to this resource. Why not join us? Our great range of benefits will help you make powerful connections, enhance your knowledge, and get more from your profession. Find out more here.
Already a member? Login to have access.
Read the Privacy and Terms of Use statement.
Reach our members: If you would like ISOPP to host or link to your organization's oncology pharmacy resource, find out about the approval criteria and submission process here.
|
This position statement aims to provide the global oncology pharmacy community with guidance to support decisions around biosimilar use. The 11 statements cover the regulation and evaluation of biosimilars, practical issues around local implementation, the education of healthcare staff and patients, and the requirement for ongoing pharmacovigilance and outcome monitoring. |
|
The article “Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners” is published in Journal of Oncology Pharmacy Practice (JOPP). The coronavirus of 2019 pandemic has necessitated vast and rapid changes in the way oncology pharmacy services are delivered around the world. The survey results demonstrate the adaptability of the oncology pharmacy profession and highlight the importance of formal evaluation of the varied practice models to determine the evidence-based practices that enhance pharmacy services. An international survey, involving respondents from over 40 countries of oncology pharmacists and technicians was conducted via the International Society of Oncology Pharmacy Practitioners (ISOPP) and collaborating global pharmacy organizations. |
|
|
Written by hospital pharmacists for hospital pharmacists, the hub offers free access to a wealth of eLearning materials and modules, on topics relevant to hospital pharmacists, including the latest developments in the safe handling of hazardous drugs. Content is translated into English, French, Spanish, Italian, German and Dutch. The initiative is funded through an ‘arms-length’ grant from Becton Dickinson. However, all content, direction, marketing and administration is controlled by Cogora, publishers of Hospital Pharmacy Europe. |
|
|
Are you ready to submit your abstract? The ISOPP Research Committee has prepared a resource on how to write an abstract for a scientific meeting. A useful tool guiding you in the process of preparing a well-written abstract, especially if it is your first time. Review the guide for some 'tips and tricks'. |
|
|
A document intended to serve as a guideline during the development of a dose-rounding policy and to support and validate existing policies. Endorsed by ISOPP as per ISOPP's endorsement guidlines. |
|
|
The purpose of the NCCN Chemotherapy Order Templates is to enhance patient safety by allowing you to standardize patient care, reduce medication errors, and anticipate and manage adverse events. The NCCN Templates include systemic therapies such as chemotherapy and immunotherapy (along with information such as dosing, route of administration, and duration of infusion), supportive care recommendations, monitoring parameters, and safety instructions. |
|
|
A new FDA website that makes getting information easy. Pharmaceutical databases. |
|
Safe handling of cytotoxic drugs |
|
Would you like to see one of ISOPP's Symposia held in your city or country? Contact services@isopp.org. |
|
|
1988 to 2012 - compiled by: Helen M McKinnon |
|
Newsletter - Volume 26 | No.10 | October 2024 |
|
|
Newsletter - Volume 26 | No.9 | September 2024 |
|
|
Newsletter - Volume 26 | No.8 | August 2024 |
|
|
Newsletter - Volume 26 | No.7 | July 2024 |
|
|
Newsletter - Volume 26 | No.6 | June 2024 |
|
|
Newsletter - Volume 26 | No.5 | May 2024 |
|
|
Newsletter - Volume 26 | No.4 | April 2024 |
|
|
Newsletter - Volume 26 | No. 3 | March 2024 |
|
|
Newsletter - Volume 26 | No. 2 | February 2024 |
|
|
Newsletter - Volume 26 | No. 1 | January 2024 |
|
|
Newsletter - Volume 25 | No. 3 | October 2023 |
|
|
Newsletter - Volume 25 | No. 2 | June 2023 |
|
|
Newsletter - Volume 25 | No. 1 | March 2023 |
|
|
Newsletter - Volume 24 | No. 4 | December 2022 |
|
|
Newsletter - Volume 24 | No. 3 | September 2022 |
|
|
Newsletter - Volume 24 | No. 2 | June 2022 |
|
|
Newsletter - Volume 24 | No. 1 | April 2022 |
|
|
Newsletter - Volume 23 | No. 4 | December 2021 |
|
|
Newsletter - Volume 23 | No. 3 | September 2021 |
|
|
Newsletter - Volume 23 | No. 2 | June 2021 |
|
|
Newsletter - Volume 23 | No. 1 | March 2021 |
|
|
Newsletter - Volume 22 | No. 4 | December 2020 |
|
|
Newsletter - Volume 22 | No. 2 & 3 | June and September 2020 |
|
|
Newsletter - Vol 22, No. 1. March 2020 |
|
|
Newsletter - Vol 21, No. 4. December 2019 |
|
|
Newsletter - Vol 21, No. 3. September 2019 |
|
|
Newsletter - Vol 21, No. 2. June 2019 |
|
|
Newsletter - Vol 21, No. 1. March 2019 |
|
|
Newsletter - Vol 20, No. 4. December 2018 |
|
|
Newsletter - Vol 20, No. 3. September 2018 |
|
|
Newsletter - Vol 20, No. 2. June 2018 |
|
|
Newsletter - Vol 20, No. 1. May 2018 |
|
|
Newsletter - Vol 19, No. 4. December 2017 |
|
|
Newsletter - Vol 19, No. 3. September 2017 |
|
|
Newsletter - Vol 19, No. 2. June 2017 |
|
|
Newsletter - Vol 19, No. 1. March 2017 |
|
|
Newsletter - Vol 18, No. 4. December 2016 |
|
|
Newsletter - Vol 18, No 3. September 2016 |
|
|
Newsletter - Vol 18, No 2. June 2016 |
|
|
Newsletter - Vol 18, No 1. March 2016 |
|
|
Newsletter - Vol 17, No 4. December 2015 |
|
|
Newsletter - Vol 17, No 3. September 2015 |
|
|
Newsletter - Vol 17, No 2. June 2015 |
|
|
Newsletter - Vol 17, No 1. March 2015 |
|
|
Newsletter - Vol 16, No 4. December 2014 |
|
|
Newsletter - Vol 16, No 3. September 2014 |
|
|
Newsletter - Vol 16, No 2. June 2014 |
|
|
Newsletter - Vol 16, No 1. March 2014 |
|
|
Newsletter - Vol 15, No 4, December 2013 |
|
|
Newsletter - Vol 15, No 3. October 2013 |
|
|
Newsletter - Vol 15, No 2. June 2013 |
|
|
Newsletter - Vol 5, No 1. March 2003 |
|
|
Newsletter - Vol 15, No 1. March 2013 |
|
|
Newsletter - Vol 14, No 4. December 2012 |
|
|
Newsletter - Vol 14, No 3. September 2012 |
|
|
Newsletter - Vol 14, No 2. June 2012 |
|
|
Newsletter - Vol 14, No 1. March 2012 |
|
|
Newsletter - Vol 13, No 4. December 2011 |
|
|
Newsletter - Vol 13, No 3. September 2011 |
|
|
Newsletter - Vol 13, No 2. June 2011 |
|
|
Newsletter - Vol 13, No 1. March 2011 |
|
|
Newsletter - Vol 12, No 4. December 2010 |
|
|
Newsletter - Vol 12, No 2. September 2010 |
|
|
Newsletter - Vol 12, No 2. June 2010 |
|
|
Newsletter - Vol 12, No 1. March 2010 |
|
|
Newsletter - Vol 11, No 4. December 2009 |
|
|
Newsletter - Vol 11, No 3. September 2009 |
|
|
Newsletter - Vol 11, No 2. July 2009 |
|
|
Newsletter - Vol 11, No 1. March 2009 |
|
|
Newsletter - Vol 10, No 3. December 2008 |
|
|
Newsletter - Vol 10, No 2. August 2008 |
|
|
Newsletter - Vol 10, No 1. March 2008 |
|
|
Newsletter - Vol 9, No 4. December 2007 |
|
|
Newsletter - Vol 9, No 3. September 2007 |
|
|
Newsletter - Vol 9, No 2. June 2007 |
|
|
Newsletter - Vol 9, No 1. March 2007 |
|
|
Newsletter - Vol 8, No 4. December 2006 |
|
|
Newsletter - Vol 8, No 3. September 2006 |
|
|
Newsletter - Vol 8, No 2. June 2006 |
|
|
Newsletter - Vol 8, No 1. March 2006 |
|
|
Newsletter - Vol 7, No 4. December 2005 |
|
|
Newsletter - Vol 7, No 3, September 2005 |
|
|
Newsletter - Vol 7, No 2. June 2005 |
|
|
Newsletter - Vol 7, No 1. March 2005 |
|
|
Newsletter - Vol 6, No 4. December 2004 |
|
|
Newsletter - Vol 6, No 3. September 2014 |
|
|
Newsletter - Vol 6, No 2. June 2004 |
|
|
Newsletter - Vol 6, No 1. March 2004 |
|
|
Newsletter - Vol 5, No 2. June 2003 |
|
|
Newsletter - Vol 5, No 3. September 2003 |
|
|
Newsletter - Vol 5, No 4. December 2003 |
|
|
Newsletter - Volume 26 | No.10 | October 2024 |
|
|
Newsletter - Volume 26 | No.9 | September 2024 |
|
|
Newsletter - Volume 26 | No.8 | August 2024 |
|
|
Newsletter - Volume 26 | No.7 | July 2024 |
|
|
Newsletter - Volume 26 | No.6 | June 2024 |
|
|
Newsletter - Volume 26 | No.5 | May 2024 |
|
|
Newsletter - Volume 26 | No.4 | April 2024 |
|
|
Newsletter - Volume 26 | No. 3 | March 2024 |
|
|
Newsletter - Volume 26 | No. 2 | February 2024 |
|
|
Newsletter - Volume 26 | No. 1 | January 2024 |
|
|
Newsletter - Volume 25 | No. 3 | October 2023 |
|
The American Society of Clinical Oncology (ASCO) has updated its guidelines to prevent and manage nausea and vomiting caused by antineoplastic agents or radiation therapy in cancer patients. |
|
|
The purpose of Hematopoietic Stem Cell Transplantation (HSCT) E-learning Tool is to provide basic knowledge to hospital and community pharmacists involved in the pharmaceutical care for HSCT patients. Become a member to have access! |
|
|
Designed to help hospitals and ambulatory care centers throughout the world evaluate oncology medication safety |
|
|
These draft guidelines are open for public consultation from 29 May 2017 to 23 June 2017. |
|
|
Provides health professionals with peer-maintained information about best practice in cancer treatment |